Skip to main content

Tharimmune Inc. (THAR) Stock

Tharimmune Inc. Stock Details, Movements and Public Alerts

Stock Details

Tharimmune Inc. (THAR), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $4.83. Over the past 52 weeks, it has ranged between $0.95 and $9.08. This places the current price at 53.2% of its 52-week high and 407.4% above its 52-week low. Recent trading volume was recorded at 440. The 14-day Relative Strength Index (RSI) stands at 53.19, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $2.71 by 78.23%. Similarly, it is above its 200-day moving average of $2.36 by 104.66%. The MACD histogram is -0.01, indicating bearish momentum (MACD Line: 0.06, Signal Line: 0.07). There is currently 1 active alert set for THAR by users.

52-Week Range

$9.08 - $0.95

-46.81% from high · +407.35% from low

Avg Daily Volume

506,521

20-day average

100-day avg: 1,145,251

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

28.74

EV/EBITDA

-6.32

EPS (TTM)

-$3.68

Beta

1.45

Similar volatility to market

Q:How is THAR valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is THAR's risk profile compared to the market?
With a beta of 1.45, Tharimmune Inc. is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 28.74 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

Return on Equity

-225.00%

Return on Assets

-99.80%

Revenue Growth (YoY)

0.00%

Earnings Growth (YoY)

0.00%

Q:How profitable and efficient is THAR's business model?
Profitability metrics are not available for this stock.
Q:What are THAR's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$177.1M

Revenue (TTM)

$0

Revenue/Share (TTM)

$0.00

Shares Outstanding

39.53M

Book Value/Share

$0.85

Asset Type

Common Stock

Q:What is THAR's market capitalization and position?
Tharimmune Inc. has a market capitalization of $177.1M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 39.53M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
Q:How does THAR's price compare to its book value?
Tharimmune Inc.'s book value per share is $0.85, while the current stock price is $4.83, resulting in a price-to-book (P/B) ratio of 5.66. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$5.00

3.52% upside potential

Analyst Recommendations

No analyst ratings available

Q:How reliable are analyst predictions for THAR?
0 analysts cover THAR with 0% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The bearish sentiment could create opportunity if analysts are wrong. The consensus target of $5.00 implies 3.5% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on THAR?
Current analyst recommendations:The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Feb 15, 2026, 02:20 AM

Technical Indicators

RSI (14-day)

53.19

Neutral

50-Day Moving Average

$2.71

78.23% above MA-50

200-Day Moving Average

$2.36

104.66% above MA-200

MACD Line

0.06

MACD Signal

0.07

MACD Histogram

-0.01

Bearish

Q:What does THAR's RSI value tell investors?
The RSI (Relative Strength Index) for THAR is currently 53.19, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
Q:How should traders interpret THAR's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.06 below the signal line at 0.07, with histogram at -0.01. This bearish crossover indicates downward pressure. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($2.71) is above the 200-day MA ($2.36), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Jan 26, 2026, 12:35 AM

Active Alerts

Alert Condition
Volume change
Threshold
300%
Created
Jan 25, 2026, 06:32 PM

Stay Ahead of the Market with Tharimmune Inc. Alerts

Set up price alerts for Tharimmune Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.